Central venous device-related infection and thrombosis in patients treated with moderate dose continuous-infusion

M E Eastman1, M Khorsand, D G Maki

  • 1Department of Medicine, University of Wisconsin, Madison, WI 53792, USA.

Cancer
|March 10, 2001
PubMed
Abstract

Insights

Central venous device-related infections and thrombosis are significant risks during moderate-dose interleukin-2 (IL-2) therapy. Low-dose warfarin did not prevent thrombosis, and infections were linked to immunotherapy type and thrombosis.

Area of Science:

  • Oncology
  • Immunotherapy
  • Infectious Disease

Background:

  • Moderate-dose continuous-infusion interleukin-2 (IL-2) is used for metastatic melanoma and renal cell carcinoma.
  • Central venous devices are crucial for IL-2 administration.
  • The incidence of central venous device-related bloodstream infection (DRBSI) and thrombosis (DRT) requires evaluation.

Purpose of the Study:

  • To determine the incidence of DRBSI and DRT in patients receiving moderate-dose continuous-infusion IL-2.
  • To identify risk factors associated with DRBSI and DRT.
  • To assess the efficacy of low-dose warfarin in preventing DRT.

Main Methods:

  • Retrospective review of 160 patients treated with moderate-dose continuous-infusion IL-2.
  • Analysis of central venous device complications, including DRBSI and DRT.
  • Evaluation of warfarin prophylaxis and patient characteristics.

Main Results:

  • A 13% incidence of DRBSI (2 per 1000 device-days) and a 16% incidence of DRT were observed.
  • DRBSI was associated with immunotherapy type and DRT.
  • DRT was associated with DRBSI; low-dose warfarin did not prevent thrombosis.

Conclusions:

  • DRBSI and DRT are significant complications of moderate-dose IL-2 therapy.
  • The risk of DRBSI appears lower than with high-dose IL-2.
  • The risk of DRT appears higher than in patients not receiving IL-2, and low-dose warfarin was ineffective.

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...